News

The University of Alabama at Birmingham Marnix E. Heersink School of Medicine’s Department of Obstetrics and Gynecology hosted a Cervical Cancer Summit in collaboration with the O’Neal Comprehensive Cancer Center and Alabama Department of Public Health on Friday, Sept. 30, at the Marriott Birmingham Grandview Hotel as an effort to tackle cervical cancer in Alabama.

The University of Alabama at Birmingham Division of Gynecologic Oncology has received $120,000 to further ovarian cancer research from the Norma Livingston Ovarian Cancer Foundation.

October is Breast Cancer Awareness Month. According to the Centers for Disease Control and Prevention, breast cancer is the most common cancer among women in the United States after skin cancer.

Thyroid nodules are common, and while simply having irregular thyroid growths does not mean a person has cancer, everyone should check their neck on occasion and let their medical team know of any concerns. Physicians at the University of Alabama at Birmingham’s O’Neal Comprehensive Cancer Center are advancing the field of thyroid care with cutting-edge, patient-specific procedures and collaborative research investigations.

The U.S. News & World Report 2020-2021 Best Hospitals list ranks the O’Neal Comprehensive Cancer Center at UAB No. 25 in the country for cancer care. This marks the cancer center’s first top-25 ranking.

The O’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham has announced its latest O’Neal Invests grants with awards worth $950,000 that will advance new cancer-related projects and initiatives and enable competitive extramural applications.

The University of Alabama at Birmingham Marnix E. Heersink School of Medicine’s Department of Radiation Oncology researchers have identified potential targets to help overcome therapy-resistant tumors in patients with glioblastoma, the most common and devastating form of primary brain cancer. 

Over the last decade, immune checkpoint blockers, or ICBs, have revolutionized treatment for various advanced cancers, including melanoma, the most aggressive skin cancer that was considered largely incurable not long ago. However, three-fourths of advanced-melanoma patients are resistant to ICBs.

September is Gynecologic Cancer Awareness Month, so it’s a good time to learn about the risks of these types of cancer and options for prevention and screening. All women are at risk for gynecologic cancers, and those risks increase with age. The information below outlines basic facts every woman should know.

Melanoma is a highly aggressive skin cancer that frequently metastasizes, but current therapies benefit only some patients. Finding new ways to treat melanoma and other cancers is crucial because of the high prevalence of acquired resistance to currently used therapy for treating patients.

Physicians at the University of Alabama at Birmingham Marnix E. Heersink School of Medicine’s Department of Radiation Oncology recently began providing stereotactic body radiation therapy, or SBRT, to lung cancer patients at UAB Medicine’s Russell Medical Cancer Center in Alexander City, Alabama.

New recommendations from the Lancet Commission on COPD, including from Commission Chair Mark Dransfield, M.D., division director of Pulmonary, Allergy and Critical Care Medicine at the University of Alabama at Birmingham, outline ways to eliminate and control COPD worldwide.

Metastatic bladder cancer is generally incurable, so new therapies are an urgent need. Researchers at the University of Alabama at Birmingham now report a potential treatment for a quarter of bladder cancers.

Nearly 32 years ago, Jeana Nesmith Russell was beginning her dream career as a nurse in one of the University of Alabama at Birmingham’s hospital units while pursuing her graduate degree.

As the O'Neal Comprehensive Cancer Center at UAB celebrates the 50th anniversary of its first core grant from the National Cancer Institute, its comprehensive vision comes full circle in this retrospective on the history of the NCI designations that started it all.

Mothers delivering newborns at the University of Alabama at Birmingham now can donate their newborn’s umbilical cord blood to LifeSouth Cord Blood Bank, a public FDA-licensed cord blood bank of LifeSouth Community Blood Centers. Donating cord blood is painless for mother and baby, and there is no charge for the lifesaving service.

The O’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham, the only National Cancer Institute-Designated Comprehensive Cancer Center in Alabama and in a four-state region, celebrates its 50th anniversary this summer.

Andres Forero, M.D.A new University of Alabama at Birmingham research study reports that brentuximab vedotin is an effective and safe first course of treatment for older patients with Hodgkin lymphoma that cannot […]

National Cancer Survivors Day was Sunday, June 5. As frightening as a cancer diagnosis most certainly can be, the good news is that survival rates continue to improve, the number of cancer survivors continues to grow and the O’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham has resources to help patients even after they are cancer-free.

On Dec. 19, 2019, Jennifer Hanna, M.D., Clinical assistant professor in the Division of General Internal Medicine and Hospitalist with UAB Hospital Medicine at the University of Alabama at Birmingham, was diagnosed with breast cancer after a biopsy for abnormal calcifications.  

Schools are out, and summer fun has begun. Between pool days and beach trips, people are outside enjoying nature and soaking in the bright summer sun. While spending time outside has positive health benefits, the sun can be a short- and long-term enemy.

For the first time in history, the world is on a path to permanently end cervical cancer. 

Anindya Dutta, MBBS, Ph.D., and colleagues have described a novel form of gene regulation that is altered in bladder cancer, leading to the boosting of a gene pathway that helps the cancer cells survive during rapid growth.

Lung cancer is a leading cause of cancer death among men and women in the United States and is among the most common cancers worldwide. However, there are some important differences in the types, causes, affects, and outcomes of lung cancer for women.